Company: THC
Filing Date: 2025-04-29
Form Type: 10-Q
Source: 0000070318-25-000017
Chunk: 142

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-29
Form: 10-Q
Item: Part II, Item 5
Chunk 142
---
ITEM 5. OTHER INFORMATION

(c) Trading Plans

During the three months ended March 31, 2025, one of our directors adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K); the terms of this arrangement, which is intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) under the Exchange Act, are as follows:NameTitleAdoption DateExpiration DateAggregate Number of Shares of Common Stock To Be SoldJames L. BiermanDirectorFebruary 20, 2025February 20, 202620,000

Other than as disclosed above, none of our directors or Section 16 officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, during the three months ended March 31, 2025.

37